Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft FunctionAndrew Adams, Christian P. Larsen, Jordan Goldstein et al.|American Journal of Transplantation|2017Cited by 128
Baseline Prognostic Factors Do Not Predict End of Treatment Ctdna MRD Status and Have Limited Impact on MRD Prognostic Performance in DLBCLJordan Goldstein, Ash A. Alizadeh, Seok Jin Kim et al.|Blood|2024Cited by 1